The global market for Microplate Systems
is projected to reach US$950 million by 2025, driven by growing applications in
life sciences/biotechnology research, pharmaceutical drug development, food
safety testing and clinical diagnostics. Few of the macro factors priming these
end-use markets for higher growth and technology adoption include rising
healthcare burden shaped by growing population, aging population, spread of
infectious diseases, rising prevalence of chronic lifestyle diseases, need for
newer more effective drugs, and the resulting increase in healthcare R&D investments.
Microplate systems are ubiquitous laboratory equipment comprising microplates,
microplate readers, and microplate handling equipment. They play a key role in
automation of bioassays encompassing biochemical and cell-based assays. High
Throughput Screening (HTS) utilize microplates. Clinical laboratories in this
era of digital health are rapidly migrating towards the use of specialized,
electronic laboratory equipment, instruments and analytical tools. Poised to
benefit in this regard are innovative microplate systems such as multimode
readers capable of measuring photometry, fluorometry, luminometry,
time-resolved fluorometry with flexibility and high performance. The miniaturization
trend sweeping through the electronics industry is resulting in the development
of microplates in small factors. This is an important development given the increasing
miniaturization of biological assays. Benefits of performing automated assays
at the nanoliter scale include process efficiency, increase in productivity,
reduced labor and resource utilization, higher speed and quality of data
acquisition. All of these benefits are vital in the pharmaceutical industry which
is today feeling all of the challenges of declining productivity and
diminishing returns on investment. Microplates with microwells are therefore growing
in demand for use in miniaturized assay development and screening in modern
drug discovery. Read More…
Comments
Post a Comment